OTC Markets OTCQX - Delayed Quote USD

Medexus Pharmaceuticals Inc. (MEDXF)

1.8540
-0.0260
(-1.38%)
At close: May 13 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
109,540
113,054
108,096
76,701
79,660
Cost of Revenue
52,083
53,540
48,058
38,774
37,655
Gross Profit
57,457
59,514
60,038
37,927
42,005
Operating Expense
42,421
46,727
51,549
50,303
41,274
Operating Income
15,036
12,787
8,489
-12,376
731
Net Non Operating Interest Income Expense
-8,414
-13,364
-13,606
-12,223
-9,816
Other Income Expense
-3,433
683
76
20,779
-22,416
Pretax Income
3,189
106
-5,041
-3,820
-31,501
Tax Provision
-373
320
-6,262
-941
-3,237
Net Income Common Stockholders
3,562
-214
1,221
-2,879
-28,264
Diluted NI Available to Com Stockholders
3,562
-214
1,221
-2,879
-28,264
Basic EPS
0.15
-0.01
0.06
-0.15
-1.86
Diluted EPS
0.15
-0.01
0.06
-0.15
-1.86
Basic Average Shares
24,533.4670
22,321.4460
19,976.1670
19,454.1550
15,197.4190
Diluted Average Shares
24,698.7480
22,486.7270
20,523.8040
19,855.7940
15,197.4190
Total Operating Income as Reported
10,224
10,794
7,614
-14,996
-1,376
Total Expenses
94,504
100,267
99,607
89,077
78,929
Net Income from Continuing & Discontinued Operation
3,562
-214
1,221
-2,879
-28,264
Normalized Income
6,480.0500
-794.5500
1,175.4000
-18,539.4034
-8,151.4377
Interest Income
--
--
--
--
3
Interest Expense
8,414
13,364
13,606
12,223
9,816
Net Interest Income
-8,414
-13,364
-13,606
-12,223
-9,816
EBIT
11,603
13,470
8,565
8,403
-21,685
EBITDA
17,794
19,276
14,646
14,548
-15,707
Reconciled Cost of Revenue
46,128
47,985
42,330
33,027
32,183
Reconciled Depreciation
6,191
5,806
6,081
6,145
5,978
Net Income from Continuing Operation Net Minority Interest
3,562
-214
1,221
-2,879
-28,264
Total Unusual Items Excluding Goodwill
-3,433
683
76
20,779
-22,416
Total Unusual Items
-3,433
683
76
20,779
-22,416
Normalized EBITDA
21,227
18,593
14,570
-6,231
6,709
Tax Rate for Calcs
0.0002
0.0002
0.0004
0.0002
0.0001
Tax Effect of Unusual Items
-514.9500
102.4500
30.4000
5,118.5966
-2,303.4377
3/31/2021 - 11/27/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SBFMW Sunshine Biopharma, Inc.
0.1986
-0.05%
 
ETST Earth Science Tech, Inc.
0.1445
+0.35%
 
CTX.TO Crescita Therapeutics Inc.
0.5300
-3.64%
 
INNO.CN InnoCan Pharma Corporation
0.1700
+6.25%
 
CPHRF Cipher Pharmaceuticals Inc.
9.27
-0.11%
 
VREOF Vireo Growth Inc.
0.4010
+5.53%
 
CPIX Cumberland Pharmaceuticals Inc.
5.56
+5.50%
 
AVNT.TO Avant Brands Inc.
0.8900
-1.11%
 
LOVE.V Cannara Biotech Inc.
1.3400
+0.75%
 
HLUN-B.CO H. Lundbeck A/S
35.08
+14.87%